{"database": "lobbying", "table": "lobbying_activities", "rows": [[1297989, "13eccf36-2b62-4111-9d4d-80814c82d4fb", "Q3", "PHARMAVITE LLC", 286074, "PHARMAVITE LLC", 2012, "third_quarter", "FOO", "New Dietary Ingredient regulation from FDA and the negative impact of the rule if not modified\nConcern over shrinking FDA budget and its impact on GMP compliance\nConcern about adequacy of GMPs and the impact of Senator Durbin's inquiries on caffeine and supplement labeling\nUpdates on Pharmavite manufacturing expansion", "HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2012-10-12T16:39:31.123000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1297989"], "units": {}, "query_ms": 0.3557250020094216, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}